Altogether, these results suggest that the fate of metastatic CRC cells may be affected by CEACAM1-L in a cell context-dependent manner, where mutational cell background or presence/absence of other CEACAM family members in human CRC cells may override the reported anti-metastatic effect of CEACAM1-L. This evidence concerns the gene CEACAM1 and colorectal carcinoma.